Arunamata Alisa, Balasubramanian Sowmya, Punn Rajesh, Quirin Amy, Tacy Theresa A
Division of Pediatric Cardiology, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, USA.
Pediatr Cardiol. 2018 Aug;39(6):1181-1187. doi: 10.1007/s00246-018-1878-8. Epub 2018 Apr 9.
Previous studies have suggested reduced pulmonary valve annulus (PVA) growth and progression of pulmonary outflow obstruction in fetuses with tetralogy of Fallot (TOF). The goals of this study were to (1) investigate the trajectory of PVA growth in utero, and (2) compare two methods of z-score determination for fetal and postnatal PVA size by echocardiography in order to improve prenatal counseling for patients with TOF. Fetal echocardiograms (FE) at a single institution with a diagnosis of TOF between 8/2008 and 12/2015 were retrospectively reviewed. Patients included had at least 2 FEs and 1 immediate postnatal echocardiogram (TTE). Fetal and postnatal demographic, clinical, and echocardiographic data were collected. Fetal body surface area (BSA) was calculated by estimating fetal weight and height; z-scores were determined based on fetal gestational age (GA) and BSA for both FEs and TTEs. Fetal PVA z-scores by GA or BSA were then compared to postnatal PVA z-scores by BSA. Twenty-two patients with 44 FEs and 22 TTEs were included. GA at the first FE was 23 weeks ± 3.4 and 32 weeks ± 3.1 at the second FE. There was no difference in PVA z-scores (by BSA) between the first and second FE (p = 0.34), but a decrease in PVA z-scores (by BSA) between the second FE and TTE (- 1.6 ± 0.5 vs. - 2.0 ± 0.7; p = 0.01). Repeat comparison with fetal PVA z-scores indexed to GA revealed no difference in z-scores between the first and second FE, but an increase in PVA z-scores between the second FE (by GA) and TTE (by BSA) (- 4.1 ± 1.0 vs. - 2.0 ± 0.7; p < 0.0001). The rate of PVA growth between the two FEs (23 µm/day ± 9.8) and between the second FE and TTE (28 µm/day ± 42) remained comparable (p = 0.57); however, the rate of BSA increase was greater in later gestation (9 cm/day ± 3 vs. 20 cm/day ± 11; p = 0.001). In patients with TOF, the rate of PVA growth appears to remain consistent through gestation; however, somatic growth rate increases in late gestation. Fetal PVA z-scores indexed to GA are thus inaccurate in predicting postnatal PVA z-scores typically indexed to BSA. This observation should be considered during prenatal consultation and delivery planning.
既往研究提示,法洛四联症(TOF)胎儿的肺动脉瓣环(PVA)生长减缓及肺流出道梗阻进展。本研究的目的是:(1)研究子宫内PVA的生长轨迹;(2)比较两种通过超声心动图测定胎儿及出生后PVA大小的z评分方法,以改善对TOF患者的产前咨询。对2008年8月至2015年12月间在单一机构诊断为TOF的胎儿超声心动图(FE)进行回顾性分析。纳入的患者至少有2次FE及1次出生后即刻超声心动图(TTE)。收集胎儿及出生后的人口统计学、临床及超声心动图数据。通过估算胎儿体重和身高计算胎儿体表面积(BSA);基于胎儿孕周(GA)和BSA分别为FE及TTE确定z评分。然后将按GA或BSA计算的胎儿PVA z评分与按BSA计算的出生后PVA z评分进行比较。纳入22例患者,有44次FE及22次TTE。首次FE时的GA为23周±3.4周,第二次FE时为32周±3.1周。首次与第二次FE之间的PVA z评分(按BSA计算)无差异(p = 0.34),但第二次FE与TTE之间的PVA z评分(按BSA计算)降低(-1.6±0.5对-2.0±0.7;p = 0.01)。与按GA索引的胎儿PVA z评分进行重复比较显示,首次与第二次FE之间的z评分无差异,但第二次FE(按GA计算)与TTE(按BSA计算)之间的PVA z评分升高(-4.1±1.0对-2.0±0.7;p < 0.0001)。两次FE之间(23μm/天±9.8)及第二次FE与TTE之间(28μm/天±42)的PVA生长速率相当(p = 0.57);然而,孕晚期BSA增加速率更快(9cm²/天±3对20cm²/天±11;p = 0.001)。在TOF患者中,PVA生长速率在整个孕期似乎保持一致;然而,孕晚期躯体生长速率增加。因此,按GA索引的胎儿PVA z评分在预测通常按BSA索引的出生后PVA z评分时不准确。在产前咨询及分娩计划时应考虑这一观察结果。